» Articles » PMID: 11688991

Identification of Genes Differentially Induced by Hypoxia in Pancreatic Cancer Cells

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2001 Nov 2
PMID 11688991
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

A hypoxic microenvironment is characteristic of many solid tumors, including pancreatic cancer, the fifth leading cause of cancer death in the United States. Hypoxia causes the stabilization of the HIF-1 (hypoxia-inducible factor-1) transcription factor and the induction of many genes that promote angiogenesis, tumor growth, and metastasis. We performed representational difference analysis (RDA) using mRNA extracted from hypoxic and normoxic Capan-2, a human pancreatic cancer cell line. cDNAs corresponding to hypoxia-inducible genes were cloned and sequenced. We identified GPI/NLK/AMF (glucose phosphate isomerase/neuroleukin/autocrine motility factor) as a hypoxic inducible gene. In addition, hexokinase II and DEC1/Stra13, genes known to be hypoxia inducible in other systems, were found to be hypoxia inducible in our pancreatic cancer system. We thus identified three genes that are induced by hypoxia in a human pancreatic cancer, including GPI/NLK/AMF, which was not previously known to be hypoxia inducible in any other system. These genes may provide new targets for diagnosis and treatment of pancreatic cancer.

Citing Articles

The effect of HIF on metabolism and immunity.

Taylor C, Scholz C Nat Rev Nephrol. 2022; 18(9):573-587.

PMID: 35726016 PMC: 9208707. DOI: 10.1038/s41581-022-00587-8.


A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.

Kato A, Ng S, Thangasamy A, Han H, Zhou W, Raeppel S Mol Carcinog. 2021; 60(11):734-745.

PMID: 34347914 PMC: 9292374. DOI: 10.1002/mc.23339.


Role of different immune cells and metabolic pathways in modulating the immune response in pancreatic cancer (Review).

Elebo N, Fru P, Omoshoro-Jones J, Candy G, Nweke E Mol Med Rep. 2020; 22(6):4981-4991.

PMID: 33174057 PMC: 7646946. DOI: 10.3892/mmr.2020.11622.


The enhancement of glycolysis regulates pancreatic cancer metastasis.

Yang J, Ren B, Yang G, Wang H, Chen G, You L Cell Mol Life Sci. 2019; 77(2):305-321.

PMID: 31432232 PMC: 11104916. DOI: 10.1007/s00018-019-03278-z.


Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase.

Golias T, Kery M, Radenkovic S, Papandreou I Int J Cancer. 2018; 144(4):674-686.

PMID: 30121950 PMC: 6689402. DOI: 10.1002/ijc.31812.